Skip to content

Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study

Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03607383
Enrollment
40
Registered
2018-07-31
Start date
2018-02-07
Completion date
2020-04-30
Last updated
2019-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias, LDL Hyperlipoproteinemia

Keywords

statins, red rice yeast, adverse effects, cholesterol, LDL, treatment outcome, tolerability

Brief summary

Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.

Detailed description

Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Studies performed on American and Chinese populations have shown positive results. These studies need confirmation in different populations. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.

Interventions

DRUGRed Rice Yeast Extract

adults requiring moderate intensity treatment will be provided red rice yeast extracts or statins, depending on the randomization; followed for compliance and adverse effects check, and reevaluated in a final visit with blood test after 8 weeks

DRUGStatin

Statin choice is done at the discretion of the treating physician for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions, for 8 weeks

Sponsors

Saint-Joseph University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patient (\>18 years) * Indication to mild or moderate statin based on AHA 2013 guidelines * Treatment naïve

Exclusion criteria

* Allergy to rice * Renal or hepatic terminal disease * Any contra indication to statin treatment * Pregnancy wish during study period * Familial hypercholesterolemia

Design outcomes

Primary

MeasureTime frameDescription
LDL reductioneight weeksafter an eight week treatment, cholesterol LDL levels' reduction is compared in the two groups

Secondary

MeasureTime frameDescription
incidence of side effectseight weeksafter eight weeks of treatment, the incidence of side effects is studied among the red rice yeast group

Other

MeasureTime frameDescription
physician and patient satisfactioneight weeksphysician and patient satisfaction will be evaluated by a single question questionnaire: Were you satisfied by the treatment?

Countries

Lebanon

Contacts

Primary ContactMarouan Zoghbi
marouan.zoghbi@gmail.com9613552317
Backup ContactRalph Mezher
ralph.mezher.RM@gmail.com96171425999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026